scholarly journals Glaucoma medication non-compliance in Hebron, Palestine

2021 ◽  
Vol 6 (0) ◽  
pp. 10-16
Author(s):  
Riyad Banayot
Keyword(s):  
Glaucoma Medication

scholarly journals Glaucoma Medication Adherence among African Americans

2013 ◽  
Vol 90 (8) ◽  
pp. 883-897 ◽  
Author(s):  
Laura E. Dreer ◽  
Christopher A. Girkin ◽  
Lisa Campbell ◽  
Andy Wood ◽  
Liyan Gao ◽  
...  
Keyword(s):  
Medication Adherence ◽  
African Americans ◽  
Glaucoma Medication

scholarly journals Will improvement of knowledge lead to improvement of compliance with glaucoma medication?

2009 ◽  
Vol 87 (4) ◽  
pp. 468-469 ◽  
Author(s):  
Kaweh Mansouri ◽  
Tarek Shaarawy
Keyword(s):  
Glaucoma Medication

scholarly journals Will improvement of knowledge lead to improvement of compliance with glaucoma medication? Authors' reply

2009 ◽  
Vol 87 (4) ◽  
pp. 469-471 ◽  
Author(s):  
Juliette G.M.M. Hoevenaars ◽  
Jan S.A.G. Schouten ◽  
Bart van den Borne ◽  
Henny J.M. Beckers ◽  
Carroll A.B. Webers
Keyword(s):  
Glaucoma Medication

Adherence to Topical Glaucoma Medication During Hospitalization

2011 ◽  
Vol 20 (9) ◽  
pp. 573-576 ◽  
Author(s):  
Salman J. Yousuf ◽  
Leslie S. Jones
Keyword(s):  
Glaucoma Medication

Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication

2019 ◽  
Vol 556 ◽  
pp. 192-199 ◽  
Author(s):  
Rania M. Hathout ◽  
Heba A. Gad ◽  
Salma M. Abdel-Hafez ◽  
Nayera Nasser ◽  
Noha Khalil ◽  
...  
Keyword(s):  
Trojan Horse ◽  
Timolol Maleate ◽  
Glaucoma Medication

scholarly journals Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence

2013 ◽  
Vol 28 (3) ◽  
pp. 191-201 ◽  
Author(s):  
Paula Anne Newman-Casey ◽  
Jennifer S. Weizer ◽  
Michele Heisler ◽  
Paul P. Lee ◽  
Joshua D. Stein
Keyword(s):  
Systematic Review ◽  
Medication Adherence ◽  
Educational Interventions ◽  
Glaucoma Medication

scholarly journals Preservatives in glaucoma medication

2018 ◽  
Vol 102 (11) ◽  
pp. 1497-1503 ◽  
Author(s):  
David W Steven ◽  
Pouya Alaghband ◽  
Kin Sheng Lim
Keyword(s):  
Supporting Evidence ◽  
Laboratory Studies ◽  
Regulatory Requirements ◽  
Glaucoma Medication ◽  
Clinically Significant ◽  
Extensive Body ◽  
Randomised Controlled ◽  
Preservative Free

Preservatives continue to be in widespread use in ophthalmic medications due to the convenience they provide, regulatory requirements and the higher cost of alternatives. Benzalkonium chloride (BAK) remains the most commonly used preservative but there is a trend towards the use of preservative-free (PF) drops for glaucoma, although at a higher price. An extensive body of literature explores BAK toxicity on ocular structures in animal and laboratory studies (in vitro and in vivo). Non-randomised controlled studies have provided some supporting evidence of its toxicity in patients, especially in those with pre-existing ocular surface disease (OSD) or on multiple medications. However, there have been very few randomised controlled trials that compare the same medication with and without BAK preservative. Several of these trials have never been published in any peer reviewed journals. Notwithstanding, those that have been published, have not demonstrated any clear benefits of the BAK-free formulations. Short duration and exclusion of those with OSD are limitations of these studies. There is a lack of evidence of clinically significant harm from a small number of BAK preserved drops in patients without OSD. This means that generally more expensive PF glaucoma medications should only be recommended for those on poly pharmacy or those with OSD but are not necessarily required for all patients.

scholarly journals Factors predicting the success of trabeculectomy bleb enhancement with needling

2018 ◽  
Vol 102 (12) ◽  
pp. 1667-1671 ◽  
Author(s):  
Jonathan Y-X L Than ◽  
Toby S Al-Mugheiry ◽  
Jesse Gale ◽  
Keith R Martin
Keyword(s):  
Proportional Hazard ◽  
Glaucoma Medication ◽  
Safety And Efficacy ◽  
Cox Proportional Hazard ◽  
Kaplan Meier ◽  
Retrospective Audit ◽  
Lower Likelihood ◽  
Period Data ◽  
Cox Proportional Hazard Regression ◽  
Medication Risk

BackgroundBleb needling is widely used to restore flow and lower intraocular pressure (IOP) in a failing trabeculectomy. We aimed to measure the safety and efficacy of needling in a large cohort and identify factors that were associated with success and failure.MethodsThis retrospective audit included all patients who underwent needling at Addenbrooke’s Hospital, Cambridge over a 10-year period. Data were available on 91 patients (98% of patients identified), including 191 needlings on 96 eyes. Success was defined as IOP below 21 mm Hg or 16 mm Hg or 13 mm Hg consistently, without reoperation or glaucoma medication. Risk factors for failure were assessed by Cox proportional hazard regression and Kaplan-Meier curves.ResultsSuccess defined as IOP <16 mm Hg was 66.6% at 12 months and 53% at 3 years and success defined as IOP <21 mm Hg was 77.1% at 12 months and 73.1% at 3 years. Failure after needling was most common in the first 6 months. Factors that predicted failure were flat or fibrotic blebs (non-functional) and no longer injected, while success was predicted by achieving a low IOP immediately after needling. No significant complications were identified.ConclusionNeedling was most successful soon after trabeculectomy, but resuscitation of a long-failed trabeculectomy had lower likelihood of success. The safety and efficacy compare favourably with alternative treatment approaches.

Sign in / Sign up

Export Citation Format

Share Document